Wealth Enhancement Advisory Services
CGON icon

Wealth Enhancement Advisory Services’s CG Oncology CGON Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Buy
6,676
+303
+5% +$19.8K ﹤0.01% 2682
2026
Q1 		$430K Buy
6,373
+866
+16% +$49.1K ﹤0.01% 2455
2025
Q4 		$222K Buy
5,507
+22
+0.4% +$910 ﹤0.01% 3186
2025
Q3 		$208K Buy
+5,485
New +$159K ﹤0.01% 3105

Other funds holding CGON

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wealth Enhancement Advisory Services's CGON Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its CG Oncology (CGON) stake by 4.8% in Q2 2026, buying an estimated $19.8K and bringing the position to 6,676 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

Wealth Enhancement Advisory Services first reported a position in CGON in Q3 2025 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Wealth Enhancement Advisory Services held 6,676 shares of CG Oncology worth $502K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 303 CG Oncology shares in Q2 2026, an estimated $19.8K.
  • CG Oncology made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2682 holding.
  • Wealth Enhancement Advisory Services first reported a position in CG Oncology in Q3 2025 and has held it in 4 quarters since.
  • 12 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.